An Open-Label, Expanded Access Protocol of Iniparib in Combination With Gemcitabine/Carboplatin in Patients With ER-, PR-, and HER2-Negative Metastatic Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Aug 2012
At a glance
- Drugs Carboplatin; Gemcitabine; Iniparib
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 Apr 2011 Additional lead trial investigator (Specht Jennifer) identified as reported by University of Washington Health Sciences.
- 26 Apr 2011 New source identified and integrated (University of Washington Health Sciences; 1009).
- 31 May 2010 New trial record